Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-22-006614
Filing Date
2022-03-11
Accepted
2022-03-11 15:59:00
Documents
80
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10ka.htm   iXBRL 10-K/A 1329108
2 ex31-1.htm EX-31.1 11097
3 ex31-2.htm EX-31.2 11443
4 ex32-1.htm EX-32.1 10459
  Complete submission text file 0001493152-22-006614.txt   7497090

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mtnb-20211231.xsd EX-101.SCH 53435
6 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mtnb-20211231_cal.xml EX-101.CAL 65995
7 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mtnb-20211231_def.xml EX-101.DEF 190824
8 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mtnb-20211231_lab.xml EX-101.LAB 461631
9 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mtnb-20211231_pre.xml EX-101.PRE 353350
74 EXTRACTED XBRL INSTANCE DOCUMENT form10ka_htm.xml XML 1446038
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

EIN.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38022 | Film No.: 22733017
SIC: 2834 Pharmaceutical Preparations